Salvage chemotherapy with rituximab DHAP (RDHAP) for relapsed non-hodgkin lymphoma (NHL): A phase II trial in the North Central Cancer Treatment Group
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Mayo Clinic, June E. Nylen Cancer Center, Duluth Clinic
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2336367416
